MENU
EXEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Exelixis (EXEL) Earnings Date & Reports
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
EXEL is expected to report earnings to fall 2.38% to 84 cents per share on August 05
Q2'26
Est.
$0.85
Q1'26
Beat
by $0.10
Q4'25
Beat
by $0.17
Q3'25
Beat
by $0.09
Q2'25
Beat
by $0.11
The last earnings report on May 05 showed earnings per share of 87 cents, beating the estimate of 76 cents. With 2.57M shares outstanding, the current market capitalization sits at 12.90B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of small molecule therapies for the treatment of cancer
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
4600
Web
https://www.exelixis.com